Tianeptine sodium is the sodium salt form of tianeptine, an atypical tricyclic antidepressant that works by enhancing serotonin reuptake rather than inhibiting it. It also acts as a full agonist at your µ-opioid receptors, which triggers downstream dopamine release and produces analgesic and mood-altering effects you won’t find with standard SSRIs. It’s approved in parts of Europe, Asia, and Latin America but lacks FDA approval in the U.S. Below, you’ll find exactly why that distinction matters.
What Is Tianeptine Sodium?
Tianeptine sodium is the sodium salt form of tianeptine, an atypical tricyclic antidepressant developed in the 1960s by the French Society of Medical Research. If you’re researching what is tianeptine sodium, you should know it functions as a selective serotonin reuptake enhancer and modulates glutamatergic neurotransmission to promote neuroplasticity. At higher doses, it activates mu-opioid receptors, producing opioid agonist effects. Marketed under brand names Stablon, Tatinol, and Coaxil, it’s approved in Europe, Asia, and Latin America but lacks FDA approval in the United States. Despite this, you’ll find tianeptine sodium supplement products sold online and in convenience stores. Understanding tianeptine sodium drug information is critical because its receptor-level activity at opioid sites carries significant dependence and abuse risks. Long-term use can lead to tolerance, and severe cases of misuse have resulted in emergency department visits and fatalities, particularly as reported in Tennessee. Research has also demonstrated that tianeptine has significant anxiolytic properties, making it useful in the treatment of panic disorder. It is also contraindicated in individuals with a history of substance abuse or those with severe renal or hepatic impairment, making medical guidance essential before use.
What Makes Tianeptine Sodium Different From SSRIs?
Understanding how tianeptine sodium works at the receptor level reveals why it stands apart from conventional SSRIs. While SSRIs block serotonin reuptake, tianeptine sodium actually enhances serotonin uptake and operates independently from monoamine transporters. Its tianeptine sodium effects also involve glutamatergic modulation, offering a distinct neurochemical pathway.
Three key mechanistic differences define this compound:
What makes tianeptine sodium mechanistically unique isn’t one difference, it’s the convergence of three distinct pharmacological pathways.
- µ-Opioid receptor agonism, Tianeptine sodium opioid receptor activity directly stimulates µ-receptors, producing mood-altering and analgesic properties absent in SSRIs.
- Serotonin uptake enhancement, Rather than inhibiting reuptake, it increases serotonin clearance from synaptic clefts.
- Minimal cytochrome P450 metabolism, This reduces drug-drug interaction potential considerably.
However, the opioid mechanism underscores tianeptine sodium risks, particularly dose-dependent sedation, euphoria, and misuse potential that SSRIs don’t carry.
Tianeptine Sodium Side Effects: From Mild to Severe
Because tianeptine sodium engages µ-opioid receptors alongside glutamatergic and serotonergic pathways, its side effect profile spans multiple organ systems and severity tiers.
| Severity | Effect | Mechanism |
|---|---|---|
| Common (>1%) | Dry mouth (up to 20%), constipation (up to 15%), insomnia (up to 20%) | Autonomic receptor modulation reducing secretory and motility functions |
| Uncommon (0.1, 1%) | Palpitations, orthostatic hypotension, tremors | Cardiovascular receptor dysregulation and neuromuscular signaling disruption |
| Rare (<0.1%) | Hepatitis, respiratory depression, ECG conduction abnormalities | Hepatotoxic metabolite accumulation, µ-opioid-mediated brainstem suppression, cardiac ion channel interference |
At supratherapeutic doses, µ-opioid receptor saturation drives respiratory depression, a life-threatening emergency. You should also know that prolonged use triggers receptor adaptation, producing withdrawal symptoms including tremors, sweating, and severe agitation upon abrupt discontinuation.
Tianeptine Sodium’s Opioid Risk: Dependence and Overdose
Tianeptine sodium activates your mu-opioid receptors as a full agonist, triggering dopamine release and producing the same euphoria-driven reinforcement cycle that drives opioid addiction, reflecting tianeptine symptoms. As your tolerance builds, you’ll need escalating doses to achieve the same effect, a pattern that rapidly entrenches physical dependence and produces withdrawal symptoms clinically indistinguishable from opioid abstinence. At recreational doses reaching up to 3,000 mg daily, far exceeding the 25, 50 mg therapeutic range, you face respiratory depression, coma, and death, with overdoses requiring naloxone reversal just like traditional opioid emergencies.
Mu-Opioid Receptor Activation
The potency of tianeptine’s opioid activity stems from its full agonism at the mu-opioid receptor (MOR), where it binds with a Ki of 383±183 nM for human receptors. This activation triggers downstream signaling cascades you should understand:
- G-protein activation occurs at an EC50 of 194±70 nM for human MOR, initiating intracellular signaling.
- cAMP inhibition follows at an EC50 of 151±45 nM, suppressing cyclic AMP production through Gi/o coupling.
- Dopamine release results from MOR-mediated signaling, driving the euphoric and rewarding effects you’d associate with classical opioids.
Tianeptine’s MOR selectivity over delta-opioid receptors reaches nearly 200-fold in humans. Naltrexone blocks tianeptine-induced MOR activation dose-dependently, confirming that its opioid effects depend entirely on mu-receptor engagement.
Withdrawal and Dependence Risks
Once tianeptine sodium activates mu-opioid receptors repeatedly, your brain’s neuroadaptive processes drive physical dependence with striking speed. You can develop tolerance within two weeks, requiring escalating doses and redosing every four to six hours to prevent withdrawal onset. This rapid receptor downregulation mirrors classical opioid dependence patterns.
When you discontinue use, withdrawal manifests across multiple systems. You’ll likely experience agitation (reported in 21.9, 33.3% of cases), tachycardia (19.1%), nausea (33.3%), and hypertension (14.3%). Neurological symptoms include tremors, insomnia, and anxiety. Gastrointestinal distress, diarrhea, vomiting, and cramping, accompanies diaphoresis and flu-like symptoms. Importantly, 72.4% of poison control calls involved withdrawal-related complaints. Withdrawal severity correlates directly with your dosage history, duration, and frequency. Medical detoxification reduces complications compared to abrupt cessation.
Overdose and Death Reports
Beyond dependence and withdrawal, tianeptine sodium’s μ-opioid agonism carries a direct fatality risk that’s now documented across multiple U.S. jurisdictions. Postmortem analyses confirm tianeptine as the primary toxic agent in accidental deaths, with blood concentrations ranging from 2.0, 8.4 mg/L detected via LC-MS-MS.
Key fatality data you should know:
- Texas cases, Two fatal intoxications showed pulmonary edema and respiratory depression consistent with μ-opioid receptor overstimulation.
- New Jersey deaths, Six tianeptine-involved overdose fatalities occurred between June 2023 and March 2024, often with co-detected substances like buprenorphine and mitragynine.
- National trend, U.S. poison center exposure calls surged from 4 in 2013 to 350 in 2024.
Tolerance development through chronic μ-opioid activation may elevate lethal thresholds, complicating dose-response predictions.
How Tianeptine Sodium Is Dosed and Prescribed Abroad
Although tianeptine sodium has never received FDA approval in the United States, several countries across Europe, Asia, and Latin America prescribe it as a regulated antidepressant under strict dosing protocols. You’ll find the standard regimen set at 12.5 mg administered orally every eight hours, yielding a total daily intake of 37.5 mg for adults.
If you’re an older adult or have compromised renal function, prescribers cap your daily dose at 25 mg to prevent accumulation and receptor overstimulation. Clinicians also monitor your liver function throughout treatment, given documented reports of hepatic injury. You should take tianeptine sodium with or without food, maintain consistent dosing for several weeks to achieve full therapeutic benefit, and never discontinue abruptly, doing so risks withdrawal driven by opioid receptor adaptation.
Is Tianeptine Sodium Legal Where You Live?
Whether you can legally purchase tianeptine sodium depends entirely on your jurisdiction, as regulatory frameworks vary dramatically across countries and even within the United States. At the federal level, the DEA hasn’t classified tianeptine as a controlled substance, but the FDA has declared it unlawful in dietary supplements and food products, leaving you in a gray zone where the compound isn’t approved yet isn’t uniformly prohibited. Meanwhile, several U.S. states have moved independently to schedule tianeptine alongside controlled opioids, and international governments range from approving it as a prescription antidepressant to banning it outright.
Global Regulatory Overview
Because tianeptine sodium acts as a full mu-opioid receptor agonist at higher doses, its regulatory status varies sharply across jurisdictions, driven largely by each country’s assessment of its abuse liability and overdose potential, reflecting emerging trends in addiction treatment.
- Approved markets: France, Spain, and parts of Latin America and Asia authorize tianeptine for depression and anxiety under strict pharmaceutical oversight.
- Restricted or banned: Italy classified it as a Class I controlled substance in 2020, Russia schedules it alongside benzodiazepines, and Bahrain enacted controls in 2003, all citing mu-opioid-mediated dependence risk.
- No authorization: The U.S. FDA, UK MHRA, and Health Canada haven’t approved tianeptine sodium for any indication, yet you’ll still find it marketed illegally as supplements or nootropics.
You should verify your local regulations before considering any product containing this compound.
US State Restrictions
The United States lacks a federal controlled-substance classification for tianeptine sodium, but the regulatory landscape at the state level has shifted rapidly as poison-control data and emergency-department reports expose the compound’s mu-opioid receptor agonism at supratherapeutic doses, reflecting tianeptine products linked to serious harm overdoses death. Alabama, Florida, Georgia, Ohio, and Kentucky have placed tianeptine under Schedule I, effectively equating its abuse potential with substances that carry no accepted medical use. Michigan, Oklahoma, Tennessee, and Arkansas classify it as Schedule II, acknowledging high misuse liability while permitting tightly regulated access.
Delaware enacted Schedule I classification in March 2025, and the bipartisan STAND Act proposes federal Schedule III placement. Over 30 states still impose no specific controls, meaning you should verify your state’s current scheduling before assuming legality where you live.
Why the FDA Says to Avoid Tianeptine Products Online
Although tianeptine activates mu-opioid receptors in the brain, producing dose-dependent analgesia, euphoria, and respiratory depression, the FDA hasn’t approved it for any medical use in the United States. The agency classifies it as an unsafe food additive that fails to meet the statutory definition of a dietary ingredient.
The FDA warns you to avoid tianeptine products online for three key reasons:
- Unpredictable dosing: U.S. products deliver 1.3 to 250 times the recommended foreign therapeutic dose, dramatically increasing receptor saturation and overdose risk.
- Severe adverse events: Reports include seizures, loss of consciousness, hospitalization, and death linked to products like Neptune’s Fix.
- Dangerous drug interactions: Tianeptine’s opioid receptor activity creates life-threatening pharmacological interactions with other CNS depressants.
Reach Out and Take Back Control
Substance use can quietly damage your health, strain your relationships, and disrupt your daily routine, but recovery is possible with the support you need. At Simonds Recovery Centers, we offer personalized Addiction Treatment Programs with experienced therapists and addiction specialists ready to guide you toward healing. Call +1 (833) 781-8338 today and begin your journey to a healthier, drug-free life.
Frequently Asked Questions
Can Tianeptine Sodium Be Used to Treat Irritable Bowel Syndrome?
You shouldn’t use tianeptine sodium to treat irritable bowel syndrome, as no clinical trials support this application. While it modulates mucosal serotonin levels by enhancing reuptake via SSRE activity and engages mu-opioid receptors, these mechanisms haven’t been validated for IBS pathophysiology. Its glutamatergic normalization through AMPA/NMDA receptor modulation and HPA axis stabilization may indirectly ease stress-related GI symptoms, but you’d be relying on untested, theoretical pathways with significant misuse risks.
How Does Tianeptine Sodium Affect the Brain’s Glutamatergic System?
Tianeptine sodium enhances your brain’s glutamatergic system by increasing phosphorylation of AMPA and NMDA receptor subtypes postsynaptically through intracellular Ca²⁺-dependent mechanisms. It facilitates signal transduction at the CA3 commissural associational synapse and normalizes glutamatergic tone in ways that differ from SSRIs. Under stress, it inhibits excess extracellular glutamate release in the basolateral amygdala, protects against synaptic vesicle reorganization, and modulates glial glutamate transporter expression to restore neuroplasticity.
Is Tianeptine Sodium Effective for Treating Anxiety or Panic Disorder?
Tianeptine sodium shows anxiolytic potential through several mechanisms you should understand. It normalizes your HPA axis activity, reducing cortisol release, while stabilizing glutamatergic signaling via NMDA and AMPA receptors. It also modulates your GABAergic system to enhance inhibitory tone. However, large-scale anxiety-specific trials don’t currently support standardized dosing, and it’s not FDA-approved. Its efficacy comparisons suggest fewer side effects than SSRIs, but you’d be relying primarily on mechanistic inferences rather than robust clinical evidence.
What Brand Names Is Tianeptine Sold Under in Other Countries?
You’ll find tianeptine marketed under several receptor-targeting formulations worldwide. Stablon dominates in France, Asia, and Latin America, while Coaxil is prescribed across Eastern Europe and Russia. Tatinol is available in China and select Asian markets. You’ll also encounter region-specific brands like Salymbra (Estonia), Tianeurax (Germany), Zinosal (Spain), Tianesal (Poland), and Tynept (India), all delivering tianeptine’s mu-opioid receptor activity through approved pharmaceutical channels.
Does Tianeptine Sodium Help With Fibromyalgia or Chronic Pain Conditions?
Tianeptine sodium may help with fibromyalgia and chronic pain, but you should know the evidence comes mostly from animal models. It activates the BDNF-CREB pathway in your medial prefrontal cortex and hippocampus, reversing stress-induced hyperalgesia. It also modulates glutamatergic neuroplasticity and engages mu-opioid receptors, which contribute to its analgesic effects. A prospective double-blind trial is currently evaluating its efficacy for fibromyalgia, but human data remain limited compared to preclinical findings.